Owen A Darr1, Justin A Colacino2, Alice L Tang3, Jonathan B McHugh4, Emily L Bellile5, Carol R Bradford1, Mark P Prince1, Douglas B Chepeha1, Laura S Rozek1,2, Jeffrey S Moyer1. 1. Department of Otolaryngology, University of Michigan Medical School, Ann Arbor, Michigan. 2. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan. 3. Department of Otolaryngology, University of Cincinnati College of Medicine, Cincinnati, Ohio. 4. Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan. 5. Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.
Abstract
BACKGROUND: Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the 2 most common cutaneous carcinomas. Molecular profiles predicting metastasis of these cancers have not been identified. METHODS: Epigenetic profiles of 37 primary cases of cutaneous SCC and BCC were quantified via the Illumina Goldengate Cancer Panel. Differential protein expression by metastatic potential was analyzed in 110 total cases by immunohistochemical (IHC) staining. RESULTS: Unsupervised hierarchical clustering analysis revealed that metastatic BCCs had a methylation profile resembling cutaneous SCCs. Metastatic cutaneous SCCs were found to be hypermethylated at FRZB (median methylation: 46.7% vs 4.7%; p = 4 × 10(-5) ). Metastatic BCCs were found to be hypomethylated at MYCL2 (median methylation: 3.8% vs 83.4%; p = 1.9 × 10(-6) ). Immunohistochemical staining revealed few differences between metastatic and nonmetastatic cancers. CONCLUSION: Metastatic primary BCCs and cutaneous SCCs had distinct epigenetic profiles when compared to their nonmetastatic counterparts. Epigenetic profiling may prove useful in future diagnosis and prevention of advanced nonmelanoma skin cancers.
BACKGROUND:Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the 2 most common cutaneous carcinomas. Molecular profiles predicting metastasis of these cancers have not been identified. METHODS: Epigenetic profiles of 37 primary cases of cutaneous SCC and BCC were quantified via the Illumina Goldengate Cancer Panel. Differential protein expression by metastatic potential was analyzed in 110 total cases by immunohistochemical (IHC) staining. RESULTS: Unsupervised hierarchical clustering analysis revealed that metastatic BCCs had a methylation profile resembling cutaneous SCCs. Metastatic cutaneous SCCs were found to be hypermethylated at FRZB (median methylation: 46.7% vs 4.7%; p = 4 × 10(-5) ). Metastatic BCCs were found to be hypomethylated at MYCL2 (median methylation: 3.8% vs 83.4%; p = 1.9 × 10(-6) ). Immunohistochemical staining revealed few differences between metastatic and nonmetastatic cancers. CONCLUSION: Metastatic primary BCCs and cutaneous SCCs had distinct epigenetic profiles when compared to their nonmetastatic counterparts. Epigenetic profiling may prove useful in future diagnosis and prevention of advanced nonmelanoma skin cancers.
Authors: M E Kupferman; T Jiffar; A El-Naggar; T Yilmaz; G Zhou; T Xie; L Feng; J Wang; F C Holsinger; D Yu; J N Myers Journal: Oncogene Date: 2010-01-18 Impact factor: 9.867
Authors: Justin A Colacino; Anna E Arthur; Dana C Dolinoy; Maureen A Sartor; Sonia A Duffy; Douglas B Chepeha; Carol R Bradford; Heather M Walline; Jonathan B McHugh; Nisha D'Silva; Thomas E Carey; Gregory T Wolf; Jeremy M G Taylor; Karen E Peterson; Laura S Rozek Journal: Epigenetics Date: 2012-06-22 Impact factor: 4.528
Authors: Matthew L Hedberg; Corbett T Berry; Ata S Moshiri; Yan Xiang; Christopher J Yeh; Cem Attilasoy; Brian C Capell; John T Seykora Journal: Int J Mol Sci Date: 2022-03-23 Impact factor: 5.923
Authors: David Hervás-Marín; Faatiemah Higgins; Onofre Sanmartín; Jose Antonio López-Guerrero; M Carmen Bañó; J Carlos Igual; Inma Quilis; Juan Sandoval Journal: PLoS One Date: 2019-12-20 Impact factor: 3.240